Systems and methods for managing clinical trials

• US 20070038472A1
• Filed: 08/09/2005
• Published: 02/15/2007
• Est. Priority Date: 08/09/2005
• Status: Abandoned Application

• Current Assignee: Clinical Supplies Management, Inc. (Clinigen Group PLC)
• Original Assignee: Clinical Supplies Management, Inc. (Clinigen Group PLC)
• Inventors: Finken, Gerald, Schlecht, Kristina
• Application Number:
  US11/199,658
• Publication Number:
  US 20070038472A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06F 16/245 Query processing
• CPC Class Codes: G06F 16/285 Clustering or classification
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass

Abstract

Improved clinical trial methods including the use of subject monitors operating separately from standard clinical trial facilities and/or protocols. The subject monitors may independently or separately contact individual subjects to reinforce trial protocols, and observe compliance levels. Databases may be built and maintained for providing indications of the quality of a clinical trial. Clinical trial materials may be provided via the use of the independently operating subject monitors.

Claims

1. A method of performing a clinical trial, the clinical trial directed by a sponsor utilizing site monitors to oversee one or more clinical investigators, each investigator having a number of study subjects, the investigator capturing study data from the subjects, the method comprising:

independently gathering data from study subjects separately from the investigators for review and input into a subject monitoring database; and

observing a quality of the study by analysis of the independently gathered data.

2. The method of claim 1 wherein the clinical trial includes the use of a patient-contact technology to gather standardized data from the patients, wherein the step of independently gathering data from study subjects is performed separately from the patient-contact technology.

3. The method of claim 1 further comprising reporting the study quality to the sponsor.

4. The method of claim 3 wherein the step of reporting the study quality includes identifying whether the independently gathered data agrees or disagrees with the previously captured study data.

5. The method of claim 3 wherein the step of reporting the study quality includes identifying whether the independently gathered data indicates whether the study exceeds a quality threshold.

6. The method of claim 1 further comprising independently distributing study drug to the study subjects independent of the investigator.

7. The method of claim 6 wherein an initial study setup is performed at each investigational site and initial drug supplies are provided to each subject at a corresponding investigational site, wherein subsequent samples are independently distributed.

8. The method of claim 7 wherein the subject monitoring database is used to monitor independent distribution of subsequent samples.

9. The method of claim 1 wherein the clinical trial is performed according to study guidelines developed with the approval of the sponsor, the method further comprising using independently gathered data recorded in the subject monitoring database to certify to the sponsor that the study has been carried out according to study guidelines.

10. The method of claim 1 wherein the step of gathering data from study subjects is completed as two way communication between the subject monitor and study subjects.

11. The method of claim 1 wherein the subject monitoring database further includes comparison data related to selected previous clinical trials, wherein the subject monitoring database is used to compare the clinical trial to the comparison data.

12. A method of performing a clinical trial, the clinical trial directed by a sponsor utilizing a network of clinical investigators, each investigator having a number of study subjects, the investigator distributing study drug to the study subjects and capturing study data from the study subjects, the method comprising:

independently performing interviews with study subjects separate from the study sites; and

independently delivering study drug to the study subjects separate from the study sites.

13. The method of claim 12 further comprising independently monitoring compliance and cognitive data separate from the study sites.

14. A method of performing a clinical trial, the method comprising:

establishing a study subject network at a number of investigator sites using a first collection of personnel;

performing study functions including study drug delivery and study result gathering using a subject monitoring group and sample delivery group for study subjects at a plurality of study sites, the subject monitoring group being separate from the first collection of personnel.

15. A method comprising:

contacting a number of subjects involved in a current clinical trial to determine whether individual subjects are experiencing the clinical trial in a correct manner and, if not, performing corrective action with respect to the individual subject and recording an intervention related to the individual subject; and

observing whether interventions occurring in the current clinical trial fall within an acceptable range by reference to a database containing information related to interventions in other clinical trials.

16. The method of claim 15 wherein the step of recording an intervention includes categorizing the intervention, wherein the step of observing whether interventions in the current clinical trial fall within an acceptable range includes comparing categorized interventions from other clinical trials to categorized interventions in the current clinical trial.

17. The method of claim 15 wherein the other clinical trials include a set of clinical trials related to testing of a substance having shared characteristics with a substance being tested in the current clinical trial.

18. The method of claim 15 wherein, within the clinical trial, a number of different sites are used, the individual subjects being spread across the number of different sites, wherein the step of recording the intervention includes noting which site the individual subject corresponds to.

19. The method of claim 18 further comprising evaluating the different sites by observing the number and types of interventions occurring in the current clinical trial for each of several different sites.